Skip to main content

Table 3 Clinicopathological and demographical information of involved population

From: Improved urine DNA methylation panel for early bladder cancer detection

 

Verification phase (RRBS)

Validation phase (qMSP)

Sample number

45

207

BC patient

28

107

Non-BC control

17

100

Among patients

 Non-BC

  IMT

2

0

  Inflammation

0

19

  Bladder stone

0

4

  Benign tumor

0

1

 BC

  Age range

48–92

29–92

  Mean age

67.9

67.2

 Stage

  Ta

11

28

  T1

6

41

  T2

5

23

  T3

4

6

  T4

2

9

  MIBC

13

54

  NMIBC

10

53

  High grade

18

58

  Low grade

10

49

  Primary

18

72

  Recurrence

10

35

  1. * IMT Inflammatory myofibroblastic tumor, MIBC Muscle invasive bladder cancer, NMIBC Non-muscle invasive bladder cancer. Pathological details were unclear or lost for some samples, these samples were excluded in relative analyses